ATE461294T1 - Brustkrebsdiagnoseverfahren - Google Patents
BrustkrebsdiagnoseverfahrenInfo
- Publication number
- ATE461294T1 ATE461294T1 AT06778773T AT06778773T ATE461294T1 AT E461294 T1 ATE461294 T1 AT E461294T1 AT 06778773 T AT06778773 T AT 06778773T AT 06778773 T AT06778773 T AT 06778773T AT E461294 T1 ATE461294 T1 AT E461294T1
- Authority
- AT
- Austria
- Prior art keywords
- breast cancer
- diagnostic procedures
- cancer diagnostic
- patient
- target genes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0552087A FR2888252A1 (fr) | 2005-07-07 | 2005-07-07 | Procede pour le diagnostic du cancer du sein |
PCT/FR2006/001593 WO2007006911A2 (fr) | 2005-07-07 | 2006-07-05 | Procede pour le diagnostic du cancer du sein |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE461294T1 true ATE461294T1 (de) | 2010-04-15 |
Family
ID=36295403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06778773T ATE461294T1 (de) | 2005-07-07 | 2006-07-05 | Brustkrebsdiagnoseverfahren |
Country Status (7)
Country | Link |
---|---|
US (1) | US20090123924A1 (de) |
EP (1) | EP1917365B1 (de) |
CN (1) | CN101258250A (de) |
AT (1) | ATE461294T1 (de) |
DE (1) | DE602006012995D1 (de) |
FR (1) | FR2888252A1 (de) |
WO (1) | WO2007006911A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070280969A1 (en) * | 2005-11-23 | 2007-12-06 | The Johns Hopkins University | RSF-1 as a prognostic marker and therapeutic target |
WO2011039734A2 (en) * | 2009-10-02 | 2011-04-07 | Enzo Medico | Use of genes involved in anchorage independence for the optimization of diagnosis and treatment of human cancer |
WO2011060380A1 (en) * | 2009-11-14 | 2011-05-19 | The Regents Of The University Of California | Pik3ca mutation status and sash1 expression predicts synergy between lapatinib and an akt inhibitor in her2 positive breast cancer |
WO2011147096A1 (en) * | 2010-05-28 | 2011-12-01 | Biomerieux | Method and kit for discriminating between breast cancer and benign breast disease |
CN102680708B (zh) * | 2012-05-14 | 2014-05-21 | 上海交通大学 | 诊断试剂盒及rnf19在制备胃癌早期诊断试剂中的应用 |
CN103602746A (zh) * | 2013-11-26 | 2014-02-26 | 浙江省肿瘤医院 | 预测乳腺癌新辅助化疗疗效的生物标记物及其用途 |
CN103920150B (zh) * | 2014-04-17 | 2016-02-03 | 北京大学第一医院 | Satb1在治疗皮肤t细胞淋巴瘤中的应用 |
CN111154859A (zh) * | 2020-01-17 | 2020-05-15 | 中国辐射防护研究院 | 一种trip12基因突变位点检测试剂盒及其用途 |
CN111172272A (zh) * | 2020-01-17 | 2020-05-19 | 中国辐射防护研究院 | Trip12基因用作辐射损伤易感性判断的分子标志物的用途 |
CN113930514A (zh) * | 2021-11-22 | 2022-01-14 | 上海市东方医院(同济大学附属东方医院) | 去泛素化酶usp25在制备诊断乳腺癌的生物标记物中的用途 |
CN114561411A (zh) * | 2022-03-14 | 2022-05-31 | 贵州大学 | Dicer1基因及其dsRNA在害虫防治中的应用 |
CN116287277A (zh) * | 2023-04-24 | 2023-06-23 | 上海生物制品研究所有限责任公司 | 胞苷脱氨酶活性的生物标记物及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7625697B2 (en) * | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
AU2002253878A1 (en) * | 2001-01-25 | 2002-08-06 | Gene Logic, Inc. | Gene expression profiles in breast tissue |
US20030099974A1 (en) * | 2001-07-18 | 2003-05-29 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer |
FR2833968A1 (fr) * | 2001-12-20 | 2003-06-27 | Ct Medico Chirurgical De Tronq | Biopuces thematiques, comportant des modules de recherche associes ou couples, leur procede de preparation, et leurs applications |
BRPI0609302A2 (pt) * | 2005-04-15 | 2011-10-11 | Becton Dickinson Co | métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse |
-
2005
- 2005-07-07 FR FR0552087A patent/FR2888252A1/fr not_active Withdrawn
-
2006
- 2006-07-05 DE DE602006012995T patent/DE602006012995D1/de active Active
- 2006-07-05 CN CNA2006800325971A patent/CN101258250A/zh active Pending
- 2006-07-05 WO PCT/FR2006/001593 patent/WO2007006911A2/fr active Application Filing
- 2006-07-05 US US11/988,364 patent/US20090123924A1/en not_active Abandoned
- 2006-07-05 AT AT06778773T patent/ATE461294T1/de not_active IP Right Cessation
- 2006-07-05 EP EP06778773A patent/EP1917365B1/de not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
FR2888252A1 (fr) | 2007-01-12 |
EP1917365B1 (de) | 2010-03-17 |
CN101258250A (zh) | 2008-09-03 |
WO2007006911A2 (fr) | 2007-01-18 |
EP1917365A2 (de) | 2008-05-07 |
WO2007006911A8 (fr) | 2008-05-08 |
US20090123924A1 (en) | 2009-05-14 |
DE602006012995D1 (de) | 2010-04-29 |
WO2007006911A3 (fr) | 2007-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE461294T1 (de) | Brustkrebsdiagnoseverfahren | |
NZ601022A (en) | Diagnosis and treatment of cancer using anti-ereg antibody | |
ES2530843T3 (es) | Métodos basados en microARN para el diagnóstico de cáncer de páncreas | |
WO2006127861A3 (en) | Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations | |
EP2667194A3 (de) | Auf Verhältnis basierende Biomarker und Verfahren zu ihrer Verwendung | |
EA200802242A1 (ru) | Способ определения того, будет или не будет пациент респондером на иммунотерапию | |
TW200745556A (en) | Biomarkers for liver fibrotic injury | |
CY1114719T1 (el) | Ανταγωνιστικα ανθρωπινου light-ειδικα ανθρωπινα μονοκλωνικα αντισωματα | |
CY1111612T1 (el) | Μεθοδος για προβλεψη της αποκρισης σε μια θεραπευτικη αγωγη με εναν αναστολεαδιmερισmου του her | |
NZ578283A (en) | Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring | |
WO2008070666A3 (en) | Compositions and methods to treat cancer with cpg rich dna and cupredoxins | |
WO2005040421A3 (en) | Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues | |
WO2008155661A3 (en) | Methods of assessing a propensity of clinical outcome for a female mammal suffering from breast cancer | |
WO2009019370A3 (fr) | Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal | |
WO2007146668A3 (en) | Use of imp3 as a prognostic marker for cancer | |
WO2009019367A3 (fr) | Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal | |
WO2010028373A3 (en) | Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients | |
WO2004078035A3 (en) | Expression profiles for breast cancer and methods of use | |
BRPI0815460A2 (pt) | kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos | |
EP1951891A4 (de) | Krebsantigen mage-a9 und verwendungen davon | |
TW200734638A (en) | Method for the diagnosis of thromboembolic and coronary heart diseases | |
WO2009019369A3 (fr) | Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal | |
ATE513929T1 (de) | Gene mit einfluss auf die menschliche gedächtnisleistung | |
WO2007071829A3 (en) | Methods and means related to diseases | |
WO2009019366A3 (fr) | Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |